General Information of the Compound
| Compound ID |
CP0448512
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[butyl-[4-[4-[[(2R)-2-hydroxy-2-[4-hydroxy-3-(methanesulfonamido)phenyl]ethyl]amino]piperidin-1-yl]phenyl]sulfamoyl]acetic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H38N4O8S2
|
||||||||||||||||||
| Molecular Weight |
598.744
|
||||||||||||||||||
| Canonical SMILES |
CCCCN(c1ccc(cc1)N1CCC(CC1)NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1)S(=O)(=O)CC(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H38N4O8S2/c1-3-4-13-30(40(37,38)18-26(33)34)22-8-6-21(7-9-22)29-14-11-20(12-15-29)27-17-25(32)19-5-10-24(31)23(16-19)28-39(2,35)36/h5-10,16,20,25,27-28,31-32H,3-4,11-15,17-18H2,1-2H3,(H,33,34)/t25-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QEABVDDCGKDZQS-VWLOTQADSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor